secwatch / observer
8-K filed May 29, 2025, 7:59 PM ET ticker CL CIK 0000021665
leadership confidence high sentiment neutral materiality 0.55

Colgate-Palmolive appoints Shane Grant as COO Americas; Parameswaran retires

COLGATE PALMOLIVE CO

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shane Grant

Chief Operating Officer, Americas
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025, 7:59 PM ET
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
Role change

Prabha Parameswaran

Vice Chair
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025, 7:59 PM ET
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
Role change

Panagiotis Tsourapas

Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025, 7:59 PM ET
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
Role change

John Hazlin

Chief Growth Officer
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025, 7:59 PM ET
and John Hazlin to the position of Chief Growth Officer
Departed

Prabha Parameswaran

Vice Chair
CL · COLGATE PALMOLIVE CO
Effective
2025-10-01
Filed
May 29, 2025, 7:59 PM ET
has communicated to the Company her intention to retire from the Company on October 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shane Grant was appointed as Chief Operating Officer, Americas at COLGATE PALMOLIVE CO.

Action
appointed
Role
Chief Operating Officer, Americas
Exact text from the filing
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Prabha Parameswaran was elected as Vice Chair at COLGATE PALMOLIVE CO.

Action
elected
Role
Vice Chair
Exact text from the filing
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Panagiotis Tsourapas changed role as Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development at COLGATE PALMOLIVE CO.

Action
promoted
Role
Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
Exact text from the filing
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Hazlin changed role as Chief Growth Officer at COLGATE PALMOLIVE CO.

Action
promoted
Role
Chief Growth Officer
Exact text from the filing
and John Hazlin to the position of Chief Growth Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Prabha Parameswaran departed as Vice Chair at COLGATE PALMOLIVE CO.

Action
intends to retire
Role
Vice Chair
Exact text from the filing
has communicated to the Company her intention to retire from the Company on October 1, 2025.
View on SEC.gov

COLGATE PALMOLIVE CO filing history →

Source: SEC EDGAR
accession 0000021665-25-000025
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.